ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • 2026 ACR/ARP PRSYM
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Fatigue"

  • Abstract Number: 2254 • ACR Convergence 2025

    Association of disease activity with insomnia, depression, and fatigue in patients with rheumatoid arthritis: a multicenter prospective observational study

    Misako Higashida-Konishi1, Keisuke Izumi2, Shuntaro Saito Saito3, Hiroki Tabata4, Satoshi Hama4, Tatsuhiro Oshige4, Yutaka Okano4, Hisaji Oshima4, Katsuya Suzuki4, Jiro Sakamoto5, Toshikazu Fukami5, Kazumichi Minato5, Nobuhiko Kajio6, Yasushi Kondo3, Hiroaki Taguchi6 and Yuko Kaneko3, 1NHO Tokyo Medical Center, Tokyo Meguroku, Japan, 2Division of Rheumatology, Department of Medicine, NHO Tokyo Medical Center/Keio University School of Medicine/TechDoctor, Inc., Tokyo, Japan, 3Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan, 4Division of Rheumatology, Department of Medicine, NHO Tokyo Medical Center, Tokyo, Japan, 5TechDoctor, Inc., Tokyo, Japan, 6Department of Rheumatology, Kawasaki Municipal Hospital, Kanagawa, Japan

    Background/Purpose: Patients with rheumatoid arthritis (RA) often experience not only joint-related symptoms but also systemic issues such as insomnia, depression, and fatigue [1–3]. These symptoms…
  • Abstract Number: 0295 • ACR Convergence 2025

    Multidimensional Analysis of Fatigue in Idiopathic Inflammatory Myopathies: Clinical, Psychological, and Sociodemographic Determinants

    Manali Sarkar1, Meera Shah2, Vincenzo Venerito3, Vikas Agarwal4 and Latika Gupta5, 1Sir H. N. Reliance Foundation Hospital and Research Centre, Mumbai, Maharashtra, India., Mumbai, Maharashtra, India, 2Indraprastha Apollo Hospital, New Delhi, Mumbai, Maharashtra, India, 3Univeristy of Bari "Aldo Moro", Italy, Bari, Bari, Italy, 4Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India, 5School of Infection, Inflammation and Immunology, College of Medicine and Health, University of Birmingham; Royal Wolverhampton NHS Trust; Centre for Musculoskeletal Research, School of Biological Sciences, The University of Manchester, Manchester; Francis Crick Institute, London, Birmingham, UK, United Kingdom

    Background/Purpose: Fatigue significantly impacts quality of life in idiopathic inflammatory myopathies (IIM) but remains poorly understood. This study aimed to identify the key determinants of…
  • Abstract Number: 2378 • ACR Convergence 2025

    Factors Associated With Fatigue In Systemic Lupus Erythematosus: Data From The Almenara Lupus Cohort

    Alvaro Oyarce-Calderón1, Rocío Gamboa-Cárdenas2, Victor Pimentel-Quiroz3, Samira Garcia-Hirsh4, Zoila Rodríguez-Bellido5, Cesar Pastor-Asurza6, Risto Perich-Campos7, Graciela Alarcón8 and Manuel Ugarte-Gil9, 1Hospital Nacional Guillermo Almenara Irigoyen, San Miguel, Lima, Peru, 2Universidad Científica del Sur, Lima, Peru, 3Universidad Científica del Sur, San Isidro, Peru, 4Hospital Nacional Guillermo Almenara Irigoyen, Lima, Peru, 5Hospital Nacional Guillermo Almenara Irigoyen; Universidad Nacional Mayor de San Marcos, Lima, Peru, 6Hospital Nacional Guillermo Almenara Irigoyen, Lima, Pakistan, 7Hospital Nacional Guillermo Almenara Irigoyen; Universidad Nacional Mayor de San Marcos, La Molina, Peru, 8The University of Alabama at Birmingham, Oakland, CA, 9Grupo Peruano de Estudio de Enfermedades Autoinmunes Sistémicas, Universidad Científica del Sur, Lima, Peru; Hospital Guillermo Almenara Irigoyen, EsSalud, Lima, Peru, Lima, Peru

    Background/Purpose: Systemic Lupus Erythematosus (SLE) is a chronic autoimmune disease characterized by a wide spectrum of clinical manifestations, fatigue being one of them; it is…
  • Abstract Number: 0379 • ACR Convergence 2025

    Do Rheumatoid Arthritis Patients have Residual Fatigue Without Swollen Joints and Laboratory Inflammation? A Multicenter Study

    Rosa Maria Morlà Novell1, Enrique González-Dávila2, Beatriz Frade Sosa3, Maria López-Lasanta4, Noemí Busquets Pérez5, Marta Valls Roc6, Meritxell Sallés Lizarzáburu7, Georgina Salvador Alarcón8, Virginia Ruiz-Esquide9, Lola Tobalina Mastre10, José Gomez-Puerta11 and Raimon Sanmartí9, 1Hospital Clínic de Barcelona, Barcelona, Spain, 2Departamento de Matemáticas. Universidad de La Laguna, Tenerife, Spain, 3Hospital Clinic de Barcelona, Barcelona, Catalonia, Spain, 4Hospital Universitari Vall d´Hebron, Barcelona, Spain, 5Hospital de Granollers, Granollers, Spain, 6Hospital Universitari Dr Trueta, Girona, Sudan, 7Xarxa Sanitària Althaia Manresa, Manresa, Spain, 8Hospital Universitari Mùtua Terrassa, Terrassa, Spain, 9Hospital Clínic de Barcelona, Barcelona, Catalonia, Spain, 10IDIBAPS. Hospital Clinic de Barcelona, Barcelona, 11Rheumatology Department, Hospital Clinic, Barcelona, Spain, Barcelona, Spain

    Background/Purpose: Residual fatigue highlights an unmet prevalent1 need in rheumatoid arthritis (RA) patients despite achieving remission of disease activity according to activity indices (DAS28).We examine…
  • Abstract Number: 2429 • ACR Convergence 2025

    mHealth-enabled Peer Coaching for Fatigue in Systemic Lupus Erythematosus (SLE): Preliminary Results from the Restore Energy, Activity Can Help (REACH) Pilot Randomized Controlled Trial

    Shanthini Kasturi1, Erin Morrissey1, Anna Deck2, Nina Gulati2, Zoe Gilbard2, Kiran Singh1, Monique Gore-Massy3, Faye Chiu4, Priscilla Calvache5, Jillian Rose-Smith5, Andre Ogura6, Lucas Ogura Dantas6, Wambui Machua7, Julia Nguyen8, Lisa Mandl5, Hocine Tighiouart1, Ludovic Trinquart2, Iris Navarro-Millan9 and Sara Folta10, 1Tufts Medical Center, Boston, MA, 2Tufts University School of Medicine, Boston, MA, 3N/A, West Orange, NJ, 4N/A, New York, NY, 5Hospital for Special Surgery, New York, NY, 6Ambulomics, Arlington, MA, 7Piedmont Healthcare, Atlanta, GA, 8Hospital for Special Surgery, New York, 9Weill Cornell Medicine, Hospital for Special Surgery, Poughkeepsie, NY, 10Tufts Friedman School of Nutrition, Boston, MA

    Background/Purpose: Fatigue is a highly prevalent and debilitating symptom affecting up to 90% of individuals living with systemic lupus erythematosus (SLE). Despite its significant impact,…
  • Abstract Number: 0380 • ACR Convergence 2025

    Multidimensional Health Assessment Questionnaire (MDHAQ)/RAPID3, is an Useful Tool to Assess Comorbid and Residual Fatigue in Rheumatoid Arthritis Patients

    Rosa Maria Morlà Novell1, Beatriz Frade Sosa2, Maria López-Lasanta3, Meritxell Sallés Lizarzáburu4, Noemí Busquets Pérez5, Georgina Salvador Alarcón6, Marta Valls Roc7, Virginia Ruiz-Esquide8, Lola Tobalina Mastre9, Raimon Sanmartí8 and José Gomez-Puerta10, 1Hospital Clínic de Barcelona, Barcelona, Spain, 2Hospital Clinic de Barcelona, Barcelona, Catalonia, Spain, 3Hospital Universitari Vall d´Hebron, Barcelona, Spain, 4Xarxa Sanitària Althaia Manresa, Manresa, Spain, 5Hospital de Granollers, Granollers, Spain, 6Hospital Universitari Mùtua Terrassa, Terrassa, Spain, 7Hospital Universitari Dr Trueta, Girona, Sudan, 8Hospital Clínic de Barcelona, Barcelona, Catalonia, Spain, 9IDIBAPS. Hospital Clinic de Barcelona, Barcelona, 10Rheumatology Department, Hospital Clinic, Barcelona, Spain, Barcelona, Spain

    Background/Purpose: Fatigue is a highly prevalent (40%-70%)1 comorbidity in rheumatoid arthritis (RA) patients, and residual fatigue has been described in a significant proportion of patients…
  • Abstract Number: 2437 • ACR Convergence 2025

    Bupropion for Lupus-Induced Fatigue Treatment (B-LIFT): A Retrospective Analysis

    Aaron Smith1, Thuyvan Phan2, Leah Luizza3, Anthony Trujillo3, Becki Cleveland1, Shruti Saxena Beem4, Tessa Englund5, Claire Timon4 and Saira Sheikh5, 1University of North Carolina, Chapel Hill, NC, 2UNC Health, Chapel Hill, NC, 3University of North Carolina, Chapel Hill, 4University of North Carolina at Chapel Hill, Chapel Hill, 5University of North Carolina at Chapel Hill, Chapel Hill, NC

    Background/Purpose: Systemic lupus erythematosus (SLE) is a chronic, multi-system autoimmune disease with heterogenous presentation. Most patients with SLE report fatigue or brain fog, which often…
  • Abstract Number: 1280 • ACR Convergence 2024

    Abnormal Cortical Gyrification Patterns in Adolescents with Childhood-onset SLE: Early Associations with Perceived Fatigue

    Diana Valdes Cabrera1, Tala El Tal2, Santiago Arciniegas1, Oscar Mwizerwa3, Asha Jeyanathan3, Lawrence Ng1, Paris Moaf1, Joanna Law4, Sarah Mossad5, Birgit Ertl-Wagner1, Ann Yeh1, Helen Branson1, Adrienne Davis6, Linda Hiraki1, Deborah Levy1, Busi Zapparoli7, Ashley Danguecan8 and Andrea Knight9, 1The Hospital for Sick Children, Toronto, ON, Canada, 2The Hospital For Sick Children & Children's Hospital of Eastern Ontario (CHEO), Ottawa, ON, The Hospital for Sick Children, Division of Rheumatology, Department of Paediatrics, University of Toronto, Toronto, ON, Canada, 3The Hospital for Sick Children, Division of Rheumatology, Department of Paediatrics, University of Toronto, The Hospital for Sick Children, Neurosciences and Mental Health, Research Institute, Toronto, ON, Canada, 4The Hospital for Sick Children, Division of Rheumatology, Department of Paediatrics, University of Toronto, Toronto, ON, Canada, 5Hospital for Sick Children, Toronto, ON, Canada, 6Division of Pediatric Emergency Medicine, Department of Pediatrics, Hospital for Sick Children and University of Toronto, Toronto, ON, Canada, 7The Hospital for Sick Children, Etobicoke, ON, Canada, 8The Hospital for Sick Children, Department of Psychology, University of Toronto, Toronto, ON, Canada, 9Division of Rheumatology, The Hospital for Sick Children; Neurosciences and Mental Health, SickKids Research Institute; Department of Paediatrics, University of Toronto, Toronto, ON, Canada

    Background/Purpose: Fatigue and brain fog are early complaints in adolescents with childhood-onset SLE (cSLE), who experience disease onset during a critical period of brain development.…
  • Abstract Number: 1320 • ACR Convergence 2024

    Acceptability and Satisfaction of an Online Resilience-Building Intervention with Peer Health Coaches for Managing Fatigue and Well-Being in Systemic Sclerosis

    Susan Murphy1, Yen Chen2, Alexandra Harper2, Nirali Shah2, Mary Alore2, Sheri Hicks2, Adam Pape3 and Dinesh Khanna2, 1University of Michigan, Plymouth, MI, 2University of Michigan, Ann Arbor, MI, 3University of Michigan, University of Michigan, MI

    Background/Purpose: Non-pharmacological fatigue management interventions in systemic sclerosis (SSc) are limited, despite people with SSc reporting that fatigue is inadequately addressed with clinical care. We…
  • Abstract Number: 1520 • ACR Convergence 2024

    The Influence of Trauma on Features of Type 2 SLE

    Jennifer Rogers1, Megan Clowse2, David Pisetsky3, Jayanth Doss4, Mithu Maheswaranathan5, Lisa Criscione-Schreiber5, Rebecca Sadun4, Kai Sun4 and Amanda Eudy6, 1Duke, Durham, NC, 2Duke University, Chapel Hill, NC, 3Duke University Medical Center, Durham, NC, 4Duke University, Durham, NC, 5Duke University School of Medicine, Durham, NC, 6Duke University, Raleigh, NC

    Background/Purpose: Type 2 SLE symptoms of fatigue, widespread pain, sleep and cognitive dysfunction occur commonly in SLE although their etiology is unknown.  Since trauma has…
  • Abstract Number: 1555 • ACR Convergence 2024

    Sustained Functional Assessment of Chronic Illness Therapy–Fatigue Response in Patients with SLE Receiving Anifrolumab Alongside Standard Therapy

    Vibeke Strand1, Kenneth Kalunian2, Ian Bruce3, Caroline Seo4, Kai Wai Lee5, Jacob Knagenhjelm6 and Catharina Lindholm6, 1Division of Immunology/Rheumatology, Stanford University, Palo Alto, CA, 2University of California San Diego, La Jolla, CA, 3Centre for Musculoskeletal Research, The University of Manchester, Manchester, United Kingdom, 4BioPharmaceuticals Medical Evidence, AstraZeneca, Gaithersburg, MD, 5Biopharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom, 6BioPharmaceuticals Medical, AstraZeneca, Gothenburg, Sweden

    Background/Purpose: Fatigue is highly prevalent and severely affects health-related quality of life (HRQoL) in patients with SLE.1,2  We previously demonstrated that, compared with placebo, a…
  • Abstract Number: 1937 • ACR Convergence 2024

    Wellness and Burnout Among Pediatric Rheumatologists in North America- A 2024 CARRA Study

    Kathryn Cook1, Aviya Lanis2, Arielle Hay3, Daniel Glaser4, Sarah Hoffmann5, Lakshmi Moorthy6, Onengiya Harry7, Deepika Singh8 and Sheetal Vora9, and for the CARRA Investigators, 1Akron Children's Hospital, Akron, OH, 2Seattle Children's Hospital, Seattle, WA, 3Nicklaus Children's Hospital, Hollywood, FL, 4Yale University School of Medicine, New Haven, CT, 5Children's Hospital of Richmond at VCU, Richmond, VA, 6Rutgers Robert Wood Johnson Medical School, Metuchen, NJ, 7Brenner Children's Hospital - Wake Forest Baptist Health, Winston-Salem, NC, 8Valley Children's Healthcare, Clovis, CA, 9Atrium Health Levine Children's Hospital, Charlotte, NC

    Background/Purpose: A high proportion of pediatricians experience burnout symptom impacting patient care and academic productivity. Burnout is a state of physical, emotional or mental exhaustion…
  • Abstract Number: 2002 • ACR Convergence 2024

    Pain and Physical Function, but Not Fatigue, Track with Disease Activity in Immune Checkpoint Inhibitor-Induced Inflammatory Arthritis

    Laura Cappelli1, Cyd Eaton1, Yunzhi Wang1, Michelle Jones2 and Clifton Bingham3, 1Johns Hopkins School of Medicine, Baltimore, MD, 2Johns Hopkins School of Medicine, Pittsburgh, PA, 3Johns Hopkins University, Baltimore, MD

    Background/Purpose: Immune checkpoint inhibitor-induced inflammatory arthritis (ICI-IA) is an impactful and often persistent side effect of cancer immunotherapy that can lead to permanent joint damage…
  • Abstract Number: 2029 • ACR Convergence 2024

    Iron Deficiency in Familial Mediterranean Fever: A Study on 211 Adult Patients from the JIR Cohort

    Ilenia Di Cola1, Lea Savey2, Marion Delplanque3, Rim bourguiba3, Alessandra Bartoli4, Zohra Aknouche3, Fatima Bensalek3, Isabelle Kone Paut5, Linda Rossi Semerano5, Isabelle Melki6, Brigitte Bader-Meunier7, Bénédicte Neven6, PIERRE QUARTIER8, Guilaine Boursier9, Irina Giurgea10, Laurence Cuisset11, Gilles Grateau3, Veronique Hentgen12 and Sophie Georgin-lavialle13, 1University of L'Aquila, L'Aquila, Italy, 2Internal Medicine Department, Tenon Hospital, AP-HP, Paris, France, france, France, 3Internal Medicine Department, Tenon Hospital, AP-HP, Paris, France, Paris, France, 4Internal Medicine Department, Tenon Hospital, AP-HP, Paris, France, italy, Italy, 5Kremlin Bicêtre hospital, Le Kremlin Bicêtre, France, 6Necker Hospital, Paris, France, 7Necker Hospital, Assistance Publique Hopitaux de Paris, Paris, France, 8Université Paris-Cite, IMAGINE Institute, Necker Children’s Hospital, Paris Cedex 15, France, 9University of Montpellier, Montpellier, 10Trousseau hospital, Paris, France, 11Cochin hospital, Paris, France, 12Laboratoire de Génétique des Maladies Rares et Autoinflammatoires, Département de Génétique Médicale, Maladies Rares et Médecine Personnalisée, CEREMAIA, CHU de Montpellier, Univ Montpellier, Montpellier, France, Le Chesnay, France, 13Sorbonne Université, Department of internal medicine, Tenon Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France

    Background/Purpose: Familial Mediterranean fever (FMF) is the most common monogenic autoinflammatory disease worldwide. Fatigue is known to trigger FMF attacks. So far, no association has…
  • Abstract Number: 2225 • ACR Convergence 2024

    Role of Fatigue in Difficult to Treat Rheumatoid Arthritis

    Maria Rodriguez-Laguna1, Leticia Leon2, Dalifer Freites Nuñez3, Cristina Hormigos-martin4, jose otazu Moudelle4, Alfredo Madrid García5, Benjamin fernandez-Gutierrez2 and lydia Abasolo Alcazar6, 1Resident in Rheumatology, Madrid, Spain, 2Hospital Clinico San Carlos, Madrid, Spain, 3Hospital Clínico San Carlos. Madrid. Spain., Madrid, Spain, 4Hospital Clínico San Carlos, madrid, Spain, 5Fundación para la Investigación Biomédica del Hospital Clínico San Carlos (IDISCC), Madrid, Madrid, Spain, 6IdISSC. HCSC, Madrid, Spain

    Background/Purpose: A subset of patients with rheumatoid arthritis (RA) who remains symptomatic after failing to multiple therapies are deemed to have "difficult-to-treat" (D2T RA). Fatigue…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • …
  • 16
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to PRYSM are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 6:00 PM CT on March 18. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology